The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment

被引:15
|
作者
Tong, Shuting [1 ]
Zhang, Peiyu [1 ]
Cheng, Qi [1 ]
Chen, Mo [1 ]
Chen, Xin [1 ]
Wang, Zitao [1 ]
Lu, Xiaoyong [1 ]
Wu, Huaxiang [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Rheumatol, Sch Med, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
gout; hyperuricemia; gut microbiota; probiotics; prebiotics; URIC-ACID; OPEN-LABEL; HYPERURICEMIA; METABOLISM; COLCHICINE; ALLOPURINOL; FEBUXOSTAT; MANAGEMENT; PROBIOTICS; PREBIOTICS;
D O I
10.3389/fcimb.2022.1051682
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Numerous studies have demonstrated that gut microbiota is essential for the host's health because it regulates the host's metabolism, endocrine, and immune systems. In recent years, increasing evidence has shown that gut microbiota plays a role in the onset and progression of gout. Changes in the composition and metabolism of the gut microbiota, result in abnormalities of uric acid degradation, increasing uric acid generation, releasing pro-inflammatory mediators, and intestinal barrier damage in developing gout. As a result, gout therapy that targets gut microbiota has drawn significant interest. This review summarized how the gut microbiota contributes to the pathophysiology of gout and how gout affects the gut microbiota. Additionally, this study explained how gut microbiota might serve as a unique index for the diagnosis of gout and how conventional gout treatment medicines interact with it. Finally, prospective therapeutic approaches focusing on gut microbiota for the prevention and treatment of gout were highlighted, which may represent a future avenue in gout treatment.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota
    Lin, Suxian
    Zhang, Tao
    Zhu, Lingxiao
    Pang, Kun
    Lu, Saisai
    Liao, Xin
    Ying, Senhong
    Zhu, Lixia
    Xu, Xin
    Wu, Jinyu
    Wang, Xiaobing
    JOURNAL OF GENETICS AND GENOMICS, 2021, 48 (09) : 781 - 791
  • [22] Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota
    Suxian Lin
    Tao Zhang
    Lingxiao Zhu
    Kun Pang
    Saisai Lu
    Xin Liao
    Senhong Ying
    Lixia Zhu
    Xin Xu
    Jinyu Wu
    Xiaobing Wang
    Journal of Genetics and Genomics, 2021, 48 (09) : 781 - 791
  • [23] Correction: Gut microbiota mediated the therapeutic efficiency of Simiao decoction in the treatment of gout arthritis mice
    Xiaoying Lin
    Mingzhu Wang
    Zhixing He
    Guifeng Hao
    BMC Complementary Medicine and Therapies, 23
  • [24] The role of gut microbiota in tumorigenesis and treatment
    Xu, Jia-Yi
    Liu, Min-Ting
    Tao, Tao
    Zhu, Xiao
    Fei, Fang-Qin
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 138
  • [25] Role of the gut microbiota in tumorigenesis and treatment
    Liu, Qingya
    Yang, Yun
    Pan, Meng
    Yang, Fan
    Yu, Yan
    Qian, Zhiyong
    THERANOSTICS, 2024, 14 (06): : 2304 - 2328
  • [26] CHANGES IN THE GUT MICROBIOTA OF GOUT PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Yin, X. Y.
    Wang, G. X.
    Song, X.
    Qiao, D.
    Su, Q. Y.
    Yu, Q.
    He, F.
    Li, X.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1848 - 1849
  • [27] Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
    Mingqian He
    Bingyin Shi
    Cell & Bioscience, 7
  • [28] Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
    He, Mingqian
    Shi, Bingyin
    CELL AND BIOSCIENCE, 2017, 7
  • [29] Gut Microbiota as a Potential Treatment Target in Patient with Chronic Heart Failure
    Joshua Henrina
    Irvan Cahyadi
    Hoo Felicia Hadi Gunawan
    Leonardo Paskah Suciadi
    SN Comprehensive Clinical Medicine, 2020, 2 (9) : 1614 - 1627
  • [30] The gut microbiota can be a potential regulator and treatment target of bone metastasis
    Contino, Kelly F.
    Yadav, Hariom
    Shiozawa, Yusuke
    BIOCHEMICAL PHARMACOLOGY, 2022, 197